White House Withdraws Nomination for New FDA Commissioner

This was the likely last attempt for the Republican-controlled Senate to name a successor.

Key Highlights

  • The White House withdrew Heidi Overton’s nomination for FDA commissioner, citing insufficient support.
  • Senator Bill Cassidy said he was disappointed and believed Overton could have secured enough votes in the full Senate.
  • Cassidy suggested some senators sought a stronger White House commitment to anti-abortion policies.
  • MAHA movement leaders also criticized Overton.
  • Kyle Diamantas has been acting FDA commissioner since Marty Makary resigned in May.

The White House has withdrawn the nomination of Heidi Overton, a senior domestic policy adviser for President Trump, for commissioner of the FDA. CIDRAP has the news.

Senator Bill Cassidy, a Louisiana Republican who currently heads the Senate Committee on Health, Education, Labor and Pensions, wrote that he was disappointed in the decision and saw a path to confirmation for Overton. The White House’s claim was that she did not have the votes required to pass, but Cassidy countered that he believed she would have had the votes to pass the full Senate.

Cassidy also suggested that some senators wanted the White House to commit more strongly to anti-abortion policies. Now, since the Senate flipped to Democratic control in the midterms, confirming a permanent FDA commissioner will fall to a newly blue majority. Some leaders of the Make America Healthy Again (MAHA) movement were also critical of Overton.

Kyle Diamantas has been the acting FDA commissioner since May, when Marty Makary, who had served for just over a year, resigned.

About the Author

Matt MacKenzie

Matt MacKenzie

Associate Editor

Matt MacKenzie is Senior Staff Writer and Associate Editor of Healthcare Purchasing News (HPN), where he leads daily news coverage and contributes in-depth features on healthcare supply chain, sterile processing, infection prevention and clinical operations. Through industry reporting and expert interviews, he examines the trends, technologies and operational challenges shaping healthcare purchasing and patient care. 

Sign up for our eNewsletters
Get the latest news and updates

Related

ID 179810040 © Josepalbert13 | Dreamstime.com
cdc_3